Table of Contents Table of Contents
Previous Page  41 / 68 Next Page
Information
Show Menu
Previous Page 41 / 68 Next Page
Page Background

J.A. Capdevila et al. / Cir Cardiov. 2016;

23(4)

:192–198

197

30. Liu YT, Alsaawi A, Bjornsson HM. Ultrasound (US) guidance for the placement of

peripheral venous access: a systematic review of randomized-controlled trials.

Eur J Emerg Med. 2014;21:18–23.

31. Chiu PC, Lee YH, Hsu HT, Feng YT, Lu IC, Chiu SL, et al. Establish a periopera-

tive check forum for peripheral intravenous access to prevent the occurrence of

phlebitis. Kaohsiung J Med Sci. 2015;31:215–21.

32. Targer IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen EA, et al. An

epidemiological study of the risks associated with peripherals intravenous

catheters. Am J Epidemiol. 1983;118:839–51.

33. O ´Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al.

Guidelines for the prevention of intravascular catheter-related infections. Infect

Control Hosp Epidemiol. 2002;23:759–69.

34. White MC. Infections and infection risks in home care settings. Infect Control

Hosp Epidemiol. 1992;13:535–9.

35. White MC, Ragland KE. Surveillance of intravenous catheter-related infections

among home care clients. Am J Infect Control. 1994;22:231–5.

36. Zakrzewska-Bode A, Muytjens HL, LiemKD, Hoogkamp-Korstanje JA. Mupirocin

resistance in coagulase-negative staphylococci, after topical prophylaxis for

the reduction of colonization of central venous catheters. J Hosp Infect.

1995;31:189–93.

37. Yébenes JC, DelgadoM, Sauca G, Serra-Prat M, SolsonaM, Almirall J, et al. Efficacy

of three different valve systems of needle-free closed connectors in avoiding

access of microorganisms to endovascular catheters after incorrect handling.

Crit Care Med. 2008;36:2558–61.

38. Ullman AJ, Cooke ML, Gillies ED, Marsh NM, Daud A, McGrail MR, et al. Opti-

mal timing for intravascular administration set replacement. Cochrane Database

Syst Rev. 2013,

http://dx.doi.org/10.1002/14651858

39. Lai KK. Safety of prolonging peripheral cannula and IV tubing use from 72 hours

to 96 hours. Am J Infect Control. 1998;26:66–70.

40. Ahlqvist M, Berglund B, Wirén M, Klang B, Johansson E. Accuracy in documen-

tation – a study of peripheral venous catheters. J Clin Nurs. 2009;18:1945–52.

41. Bregenzer T, Conen D, Sackmann P, Widmer A. Is routine replacement of periph-

eral intravenous catheters necessary? Arch Intern Med. 1998;158:151–6.

42. VanDonkP,RickardCM,McGrailMR,DoolanG.Routinereplacementversusclin-

ical monitoring of peripheral intravenous catheters in a regional hospital in the

home program: a randomized controlled trial. Infect Control Hosp Epidemiol.

2009;30:915–7.

43. Webster J, Clarke S, Paterson D, Hutton A, van Dyk S, Gale C, et al. Routine

care of peripheral intravenous catheters versus clinically indicated replacement;

randomized controlled trial. BMJ. 2008,

http://dx.doi.org/10.1136/bmj.a339

44. Webster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus

routine replacement of peripheral venous catheters. Cochrane Database Syst

Rev. 2010;3:CD007798,

http://dx.doi.org/10.1002/14651858.CD007798.pub2

45. Mestre G, Berbel C, Tortajada P, Alarcia M, Coca R, Fernández M, et al. Successful

multifaceted intervention aimed to reduce short peripheral venous catheter-

related adverse events; A quasi experimental cohort study. Am J Infect Control.

2012,

http://dx.doi.org/10.1016/j.ajic.2012.07.014,

pii: S0196-6553(12)01065-

6.

46. Grüne F, Schrappe M, Basten J, Wenchel HM, Tual E, Stützer H. Phlebitis rate and

time kinetics of short peripheral intravenous catheters. Infection. 2004;32:30–2.

47. Lee WL, Chen HL, Tsai TY, Lai IC, Chang WC, Huang CH, et al. Risk factors for

peripheral intravenous catheter infection in hospitalized patients: a prospective

study of 3165 patients. Am J Infect Control. 2009;37:683–6.

48. Giménez Pérez M. Systematic withdrawal of peripheral vein catheters: does it

salvage lives or increase costs? Med Clin. 2012;139:203–5.

49. Hasselberg D, Ivarsson B, Andersson R, Tingstedt B. The handling of peripheral

venous catheters – from non-compliance to evidence-based needs. J Clin Nurs.

2010;19:3358–563.

50. Juvé ME, Carbonell MD, Soldevila RM, Campa I, Juarez M. Mantenimiento de

catéteres venosos periféricos durantemás de 4 días. En busca de lamejor eviden-

cia. Enf Clin. 2003;13:208–16.

51. Do Rego Furtado LC. Maintenance of peripheral venous access and its impact

on the development of phlebitis: a survey of 186 catheters in a general surgery

department in Portugal. J Infus Nurs. 2011;34:382–90.

52. Bertolino G, Pitassi A, Tinelli C, Staniscia A, Guglielmana B, Scudeller L, et al.

Intermittent flushing with heparin versus saline for maintenance of peripheral

intravenous catheters in amedical department: a pragmatic cluster-randomized

controlled study. Worldviews Evid Based Nurs. 2012;9:221–6.

53. Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE, et al.

Eliminating catheter-related bloodstream infections in the intensive care unit.

Crit Care Med. 2004;32:2014–20.

54. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter.

Ann Intern Med. 1992;116:737–8.

55. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intra-

venous catheter use. Internal medicine house staff participate in a successful

quality improvement project. Arch Intern Med. 1994;154:1829–32.

56. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention

of central venous catheter-related infections by using maximal sterile barrier

precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–8.

57. Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings: recom-

mendations of the Healthcare Infection Control Practices Advisory Committee

and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp

Epidemiol. 2002;23:S3–40.

58. Yébenes JC, Capdevila JA. Infección relacionada con catéteres intravasculares.

Med Clin. 2003;121:238.

59. Bouza E, Burillo A, Mu˜noz P. Catheter-related infections: diagnosis and intravas-

cular treatment. Clin Microb Infect. 2002;8:265–74.

60. Capdevila JA, Planes AM, Palomar M, Gasser I, Pahissa A, Crespo E, et al. Value of

differential quantitative blood cultures in diagnosis of catheter related sepsis.

Eur J Clin Microbiol. 1992;11:403–7.

61. Blot F, Schmidt E, Nitemberg G, Tancredo C, Leclercq B, Laplanche A, et al. Earlier

positivity of central-venous- versus peripheral-blood cultures is highly predic-

tive of catéter-related sepsis. J Clin Microbiol. 1998;36:105–9.

62. Aygun G, Yasar H, Yilmaz M, Karasahin K, Dikmen Y, Polat E, et al. The value

of gram staining of catheter segments for rapid detection of peripheral venous

catheter infections. Diagn Microbiol Infect Dis. 2006;54:165–7.

63. Reigades E, Rodriguez-CréixemsM, Sánchez-Carrillo C, Martín-Rabadán P, Bouza

E. Uncommon aetiological agents of catheter-related bloodstream infections.

Epidemiol Infect. 2015;143:741–4.

64. Stuart RL, Cameron DR, Scout C, Kotsanas D, Grayson ML, Korman TM, et al.

Peripheral intravenous catheter-associated

Staphylococcus aureus

bacteremia:

more than 5 years of prospective data from two tertiary health services. Med J

Aust. 2013;198:551–3.

65. Trinh TT, Chan PA, Edwards O, Hollenbeck B, Huang B, Burdick N, et al. Peripheral

venous catheter-related

Staphylococcus aureus

bacteremia. Infect Control Hosp

Epidemiol. 2011;32:579–83.

66. Almirante B, Limón E, Freixas N, Gudiol F. Vincat Program. Laboratory-based

surveillance of hospital-acquired catheter-related bloodstream infections in

Catalonia. Results of the Vincat Program (2007–2010). Enf Infecc Microbiol Clin.

2012; Suppl. 3:13–9.

67. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al.

Infectious Diseases Society of America and the Society for Healthcare Epidemi-

ology of America guidelines for developing and institutional programto enhance

antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.

68. Rodríguez-Ba˜no J, Pa˜no-Pardo JR, Alvarez-Rocha L, Asensio A, Calbo E, Cerce-

nado E, et al. Grupo de Estudio de la Infección Hospitalaria-Sociedad Espa˜nola

de Enfermedades Infecciosas y Microbiología Clínica; Sociedad Espa˜nola de Far-

macia Hospitalaria; Sociedad Espa˜nola de Medicina Preventiva, Salud Pública

e Higiene. Programas de optimización de uso de antimicrobianos (PROA en

hospitales espa˜noles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH.

Enferm Infecc Microbiol Clin. 2012;30:22.e1–23,

http://dx.doi.org/10.1016/

j.eimc.2011.09.018 [Epub 2011 Dec 15].

69. Jernigan JA, Farr BM. Short-course therapy of catheter-related

Staphylococcus

aureus

bacteremia: a meta-analysis. Ann Intern Med. 1993;119:304–11.

70. Gudiol F, Aguado JM, Almirante B, Bouza B, Cercenado E, Domínguez MA, et al.

Diagnosis and treatment of bacteremia and endocarditis due to

Staphylococcus

aureus

. A clinical guideline from the Spanish Society of Clinical Microbiology and

Infectious Diseases; 2015,

http://dx.doi.org/10.1016/j.eimc.2015.03.015

71. Cisneros-Herrerosa JM, Cobo-Reinoso J, Pujol-Rojo M, Rodríguez-Ba˜no J,

Salavert-Lletíe M. Guía para el diagnóstico y tratamiento del paciente con

bacteriemia. Guías de la Sociedad Espa˜nola de Enfermedades Infecciosas

y Microbiología Clínica (SEIMC). Enferm Infecc Microbiol Clin. 2007;25:

111–30.

72. Fowler VC, Justice A, Moore C, Benjamin DK, Woods CW, Campbell S, et al. Risk

factors for haematogenous complications of intravascular catheters-associated

S. aureus

bacteremia. Clin Infect Dis. 2005;40:95–103.

73. Sanchez KT, Obeid KM, Szpunar S, Fakih MG, Khatib R. Delayed peripheral

venous catheter-related

Staphylococcus aureus

bacteremia: onset

24 hours

after catheter removal. Scand J Infect Dis. 2012;44:551–4.

74. Yoo S, Ha M, Choi D, Pai H. Effectiveness of surveillance of central catheter-

related bloodstream infection in an ICU in Korea. Infect Control Hosp Epidemiol.

2001;22:433–6.

75. Warren DK, Zack JE, Cox MJ, Cohen MM, Fraser VJ. An educational interven-

tion to prevent catheter-associated bloodstream infections in a non-teaching

community medical center. Crit Care Med. 2003;31:1959–63.

76. Warren DK, Zack JE, Mayfield JL, Chen A, Prentice D, Fraser VJ, et al. The effect

of an education program on the incidence of central venous catheter-associated

bloodstream infection in a medical ICU. Chest. 2004;126:1612–8.

77. Warren DK, Cosgrove SE, Diekema DJ, Zuccotti G, Climo MW, Bolon MK, et al. A

multicenterinterventiontopreventcatheter-associatedbloodstreaminfections.

Infect Control Hosp Epidemiol. 2006;27:662–9.

78. Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N. The effect of

process control on the incidence of central venous catheter-associated blood-

stream infections and mortality in intensive care units in Mexico. Crit Care Med.

2005;33:2022–7.

79. Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME,

et al. Effect of an education programon decreasing catheter-related bloodstream

infections in the surgical intensive care unit. Crit Care Med. 2002;30:59–64.

80. Coopersmith CM, Zack JE, Ward MR, Sona CS, Schallom ME, Everett SJ, et al. The

impact of bedside behavior on catheter-related bacteremia in the intensive care

unit. Arch Surg. 2004;139:131–6.

81. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, et al. Edu-

cation of physicians in-training can decrease the risk for vascular catheter

infection. Ann Intern Med. 2000;132:641–8.

82. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D.

Impact of a prevention strategy targeted at vascular-access care on incidence of

infections acquired in intensive care. Lancet. 2000;355:1864–8.

83. Lolom I, Deblangy C, Capelle A, Guerinot W, Bouvet E, Barry B, et al. Effect

of a long-term quality improvement program on the risk of infection related

peripheral venous catheters. Presse Med. 2009;38:34–42.